Anal cancer · 4 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Fluorouracil, Mitomycin, RT Variant #01 | — | R 5 688 | 56d | — | ~14.8 mo | — | — | — |
Capecitabine, Mitomycin, RT Variant #01 | — | R 4 214 | 42d | — | — | — | — | — |
Cisplatin and Fluorouracil (CF) and RT Variant #13 | — | R 1 850 | 28d | ~16.0 mo | ~34.5 mo | ~18 | ~R 33 301 PFS proxy · indirect | 4 |
Radiation therapy N/A - radiation Partial | — | — | 49d | — | ~9.2 mo | — | — | 1 |
4 of 4 regimens shown